Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Receivables (2024 - 2025)

Historic Receivables for Gossamer Bio (GOSS) over the last 2 years, with Q3 2025 value amounting to $9.6 million.

  • Gossamer Bio's Receivables rose 4418.36% to $9.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.6 million, marking a year-over-year increase of 4418.36%. This contributed to the annual value of $5.5 million for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Gossamer Bio's Receivables is $9.6 million, which was up 4418.36% from $8.0 million recorded in Q2 2025.
  • In the past 5 years, Gossamer Bio's Receivables registered a high of $9.6 million during Q3 2025, and its lowest value of $3.9 million during Q2 2024.